IDEAYA Biosciences Inc (NAS:IDYA)
$ 25.47 0.17 (0.67%) Market Cap: 2.19 Bil Enterprise Value: 1.29 Bil PE Ratio: 0 PB Ratio: 1.85 GF Score: 26/100

IDEAYA Biosciences Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 09, 2020 / 03:40PM GMT
Release Date Price: $12.55 (+3.12%)
Yigal Nochomovitz
Citigroup Inc. - Biotech Analyst

Okay, great. All right. Sorry about that. So again, I'm Yigal Nochomovitz. I'm one of the biotech analysts at Citi. And I'm here with Joel Beatty, my colleague, who also covers biotech. And I believe Mohit should be joining -- Mohit Bansal should be joining us soon.

As a reminder, if you have questions, you can e-mail me or you can e-mail Joel or Mohit. You can also submit a question via the showcase feature on the open exchange interface. So today, we're going to be talking about targeted therapy for oncology. So a great topic. And I'm very pleased to have with me four distinguished members of management. From Calithera, Susan Molineaux, the CEO, from IDEAYA, Yujiro Hata, also a CEO, Jacob Chacko from ORIC, another CEO, and finally, Briggs Morrison, CEO of Syndax. So welcome everyone to the panel and hope for a good discussion.

Questions & Answers

Yigal Nochomovitz
Citigroup Inc. - Biotech Analyst

So maybe we'll start with some general questions, and then we can move into some of the more

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot